EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring

Luiza Camelia Nechita, Dana Tutunaru, Aurel Nechita, Andreea Elena Voipan iD, Daniel Voipan iD, Ancuta Elena Tupu iD, Carmina Liana Musat iD

Diagnostics · 20.03.2025 · 15 (6) · 787

DOI: 10.3390/diagnostics15060787 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 20.03.2025. Verfasst von Luiza Camelia Nechita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, 'Dunarea de Jos' University of Galati, 800008 Galati, Romania. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Dunarea de Jos" University of Galati, “Dunărea de Jos” University of Galați.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of cardiovascular complications in cancer patients due to cardiotoxic treatments has necessitated advanced monitoring and predictive solutions. Cardio-oncology is an evolving interdisciplinary field that addresses these challenges by integrating artificial intelligence (AI) and smart cardiac devices. This comprehensive review explores the integration of artificial intelligence (AI) and smart cardiac devices in cardio-oncology, highlighting their role in improving cardiovascular risk assessment and the early detection and real-time monitoring of cardiotoxicity. AI-driven techniques, including machine learning (ML) and deep learning (DL), enhance risk stratification, optimize treatment decisions, and support personalized care for oncology patients at cardiovascular risk. Wearable ECG patches, biosensors, and AI-integrated implantable devices enable continuous cardiac surveillance and predictive analytics. While these advancements offer significant potential, challenges such as data standardization, regulatory approvals, and equitable access must be addressed. Further research, clinical validation, and multidisciplinary collaboration are essential to fully integrate AI-driven solutions into cardio-oncology practices and improve patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecardio-oncologycardiotoxicitycardiovascular riskdeep learningimplantable devicesmachine learningreal-time monitoringwearable devices

Autor:innen und Institutionen

  • Faculty of Medicine and Pharmacy, 'Dunarea de Jos' University of Galati, 800008 Galati, Romania.
  • Faculty of Automation, Computers, Electrical Engineering and Electronics, 'Dunarea de Jos' University of Galati, 800008 Galati, Romania.

ORCID-Profile: Andreea Elena Voipan, Daniel Voipan, Ancuta Elena Tupu, Carmina Liana Musat

Förderung

  • "Dunarea de Jos" University of Galati
  • “Dunărea de Jos” University of Galați

Zitieren

APA

Nechita, L. C., Tutunaru, D., Nechita, A., Voipan, A. E., Voipan, D., Tupu, A. E., & Musat, C. L. (2025). AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring. Diagnostics, 15(6), 787. https://doi.org/10.3390/diagnostics15060787

Vancouver

Nechita LC, Tutunaru D, Nechita A, Voipan AE, Voipan D, Tupu AE, et al. AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring. Diagnostics. 2025;15(6):787. doi:10.3390/diagnostics15060787

BibTeX
@article{Nechita2025,
  author = {Nechita, Luiza Camelia and Tutunaru, Dana and Nechita, Aurel and Voipan, Andreea Elena and Voipan, Daniel and Tupu, Ancuta Elena and Musat, Carmina Liana},
  title = {AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {6},
  pages = {787},
  doi = {10.3390/diagnostics15060787}
}
Kostenlos starten →